1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Clinical Trials
Ask MarketMind AI
427.00 1.30 (0.31%)
4.2M
NSE+BSE Volume

NSE 03 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Biocon is on 05 Aug 2026 for the purpose of Quarterly Results See details

Biocon quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents